Point mutation in essential genes with loss or mutation of the second allele: Relevance to the retention of tumor-specific antigens

Journal of Experimental Medicine

Volumn 194, Issue 3, 2001, Pages 285-299

  Beck Engeser, G B ^a   Monach, P A ^a   Mumberg, D ^a   Yang, F ^a   Wanderling, S ^a   Schreiber, K ^a   Espinosa III, R ^a   Le Beau, M M ^a   Meredith, S C ^a   Schreiber, H ^a  

^a UNIVERSITY OF CHICAGO   (United States)

Author keywords

CD4 positive T lymphocytes; Loss of heterozygosity; Point mutation; Ribosomal proteins; Tumor escape

Indexed keywords

RIBOSOME PROTEIN; TUMOR ANTIGEN;

ALLELE; ANIMAL CELL; ANTIGEN RECOGNITION; ARTICLE; CHROMOSOME 5; CHROMOSOME DELETION; CONTROLLED STUDY; GENE LOSS; HYBRIDOMA; LYMPHOCYTE SUBPOPULATION; MOUSE; NONHUMAN; POINT MUTATION; PRIORITY JOURNAL; TUMOR CELL LINE; TUMOR GROWTH;

ALLELES; AMINO ACID SEQUENCE; ANIMALS; ANTIGENS, NEOPLASM; BASE SEQUENCE; CD4-POSITIVE T-LYMPHOCYTES; DNA PRIMERS; DNA, NEOPLASM; IN SITU HYBRIDIZATION, FLUORESCENCE; MICE; MOLECULAR SEQUENCE DATA; NEOPLASMS, RADIATION-INDUCED; POINT MUTATION; RIBOSOMAL PROTEINS; RNA, MESSENGER; RNA, NEOPLASM; TUMOR CELLS, CULTURED; ULTRAVIOLET RAYS;

EID: 0035817322     PISSN: 00221007     EISSN: None     Source Type: Journal    
DOI: 10.1084/jem.194.3.285     Document Type: Article

References (63)

1. Human tumor antigens recognized by T lymphocytes
2. Cancer antigens: Immune recognition of self and altered self
3. A unique tumor antigen produced by a single amino acid substitution
4. A p161NK4a-insensitive CDK4 mutant targeted by cytolytic T lymphocytes in a human melanoma
5. A mutated intron sequence codes for an antigenic peptide recognized by cytolytic T lymphocytes on a human melanoma
6. A CASP-8 mutation recognized by cytolytic T lymphocytes on a human head and neck carcinoma
7. A mutated β-catenin gene encodes a melanoma-specific antigen recognized by tumor infiltrating lymphocytes
8. Stabilization of β-catenin by genetic defects in melanoma cell lines
9. A newly identified Minute locus, M(2)32D, encodes the ribosomal protein L9 in Drosophila melanogaster
10. Two antigens recognized by autologous cytolytic T lymphocytes on a melanoma result from a single point mutation in an essential housekeeping gene
11. Mechanisms of syngeneic tumor rejection. Susceptibility of host-selected progressor variants to various inummological effector cells
12. + T-cell-dependent surveillance
13. The innnunodominant antigen of an ultraviolet-induced regressor tumor is generated by a somatic point mutation in the DEAD box helicase p68
14. Escape of mouse mastocytoma P815 after nearly complete rejection is due to antigen-loss variants rather than immunosuppression
15. Immunoselection in vivo: Independent loss of MHC class I and melanocyte differentiation antigen expression in metastatic melanoma
16. Identification of a tumor-specific shared antigen derived from an Eph receptor and presented to CD4 T cells on HLA class II molecules
17. Highly malignant tumor variants retain tumor-specific antigens recognized by T helper cells
18. - T cells do not necessarily require recruitment of host's cytotoxic T cell precursors for implementation of in vivo immunity
19. - T cells
20. + T cells eliminate MHC class II-negative cancer cells in vivo by indirect effects of IFN-γ
21. + T cell-mediated tumor rejection involves inhibition of angiogenesis that is dependent on IFN γ receptor expression by nonhematopoietic cells
22. Mutated mitogen-activated protein kinase: A tumor rejection antigen of mouse sarcoma
23. Antigenicity of murine skin tumors induced by ultraviolet light
24. Antigenic cancer cells that escape immune destruction are stimulated by host cells
25. Inhibition of tumor growth by elimination of granulocytes
26. Tumor antigens defined by cloned immunological probes are highly polymorphic and are not detected on autologous normal cells
27. Properties of monoclonal antibodies to mouse Ig allotypes, H-2, and Ia antigens
28. Hybridoma cell lines secreting monoclonal antibodies to mouse H-2 and Ia antigens
29. Vaccination with irradiated tumor cells engineered to secrete murine granulocyte-macrophage colonystimulating factor stimulates potent, specific, and long-lasting anti-tumor immunity
30. Isolation of Chinese hamster ovary ribosomal mutants differentially resistant to ricin, abrin, and modeccin
31. Tricine-sodium dodecyl sulfate-polyacrylamide gel electrophoresis for the separation of proteins in the range from 1 to 100 kDa
32. Gene mapping by fluorescence in situ hybridization
33. Structural organization and chromosomal localization of the human ribosomal protein L9 gene
34. Proliferation, but not growth, blocked by conditional deletion of 40S ribosomal protein S6
35. The complete atomic structure of the large ribosomal subunit at 2.4 A resolution
36. Unusual resistance of peptidyl transferase to protein extraction procedures
37. Phylogenetic relationship of organisms obtained by ribosomal protein comparison
38. Cross-linking of elongation factor 2 to rat-liver ribosomal proteins by 2-iminothiolane
39. Ricin A chain can be chemically crosslinked to the mammalian ribosomal proteins L9 and L10e
40. The phosphorylation of liver ribosomal proteins in vivo. Evidence that only a single small subunit protein (S6) is phosphorylated
41. A stimulated S6 kinase from rat liver: Identity with the mitogen activated S6 kinase of 3T3 cells
42. Rapamycin selectively represses translation of the "polypyrimidine tract" mRNA family
43. Ribosome conformational changes associated with protein S6 phosphorylation
44. The peptide recognized by HLA-A68.2-restricted, squamous cell carcinoma of the lungspecific cytotoxic T lymphocytes is derived from a mutated elongation factor 2 gene
45. Initiator proteins for the assembly of the 50S subunit from Escherichia coli ribosomes
46. Selecting rRNA binding sites for the ribosomal proteins L4 and L6 from randomly fragmented rRNA: Application of a method called SERF
47. Ribosomal protein L32 of Saccharomyces cerevisiae influences both the splicing of its own transcript and the processing of rRNA
48. The bifunctional nature of ribosomal proteins and speculations on their origins
49. Extraribosomal functions of ribosomal proteins
50. Implication of mammalian ribosomal protein S3 in the processing of DNA damage
51. Homologous ribosomal protein genes on the human X and Y chromosomes: Escape from X inactivation and possible implications for Turner syndrome
52. Altered cellular responses by varying expression of a ribosomal protein gene: Sequential coordination of enhancement and suppression of ribosomal protein S3a gene expression induces apoptosis
53. Constitutive expression of human ribosomal protein L7 arrests the cell cycle in G1 and induces apoptosis in Jurkat T-lymphoma cells
54. Drosophila AP3, a presumptive DNA repair protein, is homologous to human ribosomal associated protein PO
55. Mutations in the Drosophila gene encoding ribosomal protein S6 cause tissue overgrowth
56. Chasing the cancer demon
57. The minute genes in Drosophila and their molecular functions
58. Functional equivalence of human X- and Y-encoded isoforms of ribosomal protein S4 consistent with a role in Turner syndrome
59. High frequency of autologous anti-melanoma CTL directed against an antigen generated by a point mutation in a new helicase gene
60. The immunoprotective MHC II epitope of a chemically induced tumor harbors a unique mutation in a ribosomal protein
61. Systemic alteration induced in mice by ultraviolet light irradiation and its relationship to ultraviolet carcinogenesis
62. Escape of human solid tumors from T-cell recognition: Molecular mechanisms and functional significance